Scandinavian Journal of Gastroenterology · 1995 · 30 citations · 24 references
MedicineClinical SciencesInternal MedicineClinical EpidemiologyGastroenterologyGastrointestinal PharmacotherapyPeptic Ulcer DiseasePeptic Ulcer Disease CareHistamine Receptor AntagonismHistamine Receptor AntagonistsHistamine-2 Receptor Antagonist TherapyLongitudinal Follow-up
BACKGROUND: Little is known about today's natural course of peptic ulcer disease (PUD). METHODS: A follow-up study based on a structured telephone interview was attempted in 728 patients with an endoscopic diagnosis of peptic ulcer in 1980-84. RESULTS: Seven patients (1%) died because of PUD during the 8- to 10-year follow-up period. Of the 441 interviewed patients 15.2% had experienced no further clinical manifestations of PUD, 10.9% had had bleeding and 0.7% perforation, and 17.5% had been operated on. The operated patients reported fewer symptoms (p < 0.01) during the last 2 weeks before the interview than those not operated on. On an average the unoperated patients had had symptoms and had used histamine-2-receptor antagonists (H2RA) 12 and 10 weeks per year, respectively. Long-term treatment with H2RA was reported by 18%. More than one-third (36%) of the unoperated patients stated that the symptoms had had a significant negative impact on their lives. Age at onset of disease and index ulcer, family history, use of anti-inflammatory drugs and alcohol, bleeding, and another chronic disease were found to be significant predictors of the course. CONCLUSION: In more than one-third of the patients with PUD the course is still burdened with many symptoms and complications.
24
Cimetidine, Cigarette Smoking, and Recurrence of Duodenal Ulcer
Stephen J. Sontag, David Y. Graham, Alphonso Belsito et al. · New England Journal of Medicine · 1984 · 219 citations